AKT1 and neoplasm: While all 3 drug-treated samples exhibited significant alterations in MAPK and PI3K/AKT-associated proteins, differences at the individual protein level between samples and changes in molecular dependencies following treatment reveal compensatory changes in residual cells to sustain tumor growth suppression.